These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3488506)

  • 1. Expression of the gene defect in X-linked agammaglobulinemia.
    Conley ME; Brown P; Pickard AR; Buckley RH; Miller DS; Raskind WH; Singer JW; Fialkow PJ
    N Engl J Med; 1986 Aug; 315(9):564-7. PubMed ID: 3488506
    [No Abstract]   [Full Text] [Related]  

  • 2. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.
    Fearon ER; Winkelstein JA; Civin CI; Pardoll DM; Vogelstein B
    N Engl J Med; 1987 Feb; 316(8):427-31. PubMed ID: 2880293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecto-5'-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia.
    Thompson LF; Boss GR; Spiegelberg HL; Jansen IV; O'Connor RD; Waldmann TA; Hamburger RN; Seegmiller JE
    J Immunol; 1979 Dec; 123(6):2475-8. PubMed ID: 315423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages.
    de Weers M; Verschuren MC; Kraakman ME; Mensink RG; Schuurman RK; van Dongen JJ; Hendriks RW
    Eur J Immunol; 1993 Dec; 23(12):3109-14. PubMed ID: 8258324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgH repertoire and Ig-related gene expression in X-linked agammaglobulinemia.
    Schiff C; Milili M; Le Deist F; De Saint-Basile G; Fischer A; Fougereau M
    Immunodeficiency; 1993; 4(1-4):3-12. PubMed ID: 8167721
    [No Abstract]   [Full Text] [Related]  

  • 6. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
    Callard RE; Smith SH; Herbert J; Morgan G; Padayachee M; Lederman S; Chess L; Kroczek RA; Fanslow WC; Armitage RJ
    J Immunol; 1994 Oct; 153(7):3295-306. PubMed ID: 7916370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of the molecular defect in B lymphocytes from X-linked agammaglobulinemia by cell fusion.
    Schwaber J; Koenig N; Girard J
    J Clin Invest; 1988 Oct; 82(4):1471-6. PubMed ID: 3139715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional polymorphisms useful in linkage analysis for X-linked agammaglobulinemia.
    Parolini O; Conley ME
    Immunodeficiency; 1993; 4(1-4):217-9. PubMed ID: 8167704
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic prediction in X-linked agammaglobulinaemia.
    Lau YL; Levinsky RJ; Malcolm S; Goodship J; Winter R; Pembrey M
    Am J Med Genet; 1988 Oct; 31(2):437-48. PubMed ID: 3232706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier detection and prenatal diagnosis of X-linked agammaglobulinemia.
    Journet O; Durandy A; Doussau M; Le Deist F; Couvreur J; Griscelli C; Fischer A; de Saint-Basile G
    Am J Med Genet; 1992 Jul; 43(5):885-7. PubMed ID: 1642281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDH isoenzymes in the T lymphocytes of patients with primary hypogammaglobulinaemia.
    Matamoros N; Abad E; Webster AD
    Clin Exp Immunol; 1982 Dec; 50(3):617-20. PubMed ID: 6984668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell-deficient muMT mice as an experimental model for Mycoplasma infections in X-linked agammaglobulinemia.
    Berglöf A; Sandstedt K; Feinstein R; Bölske G; Smith CI
    Eur J Immunol; 1997 Aug; 27(8):2118-21. PubMed ID: 9295053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier detection for X-linked agammaglobulinaemia (Bruton type) in an Irish family using linked DNA probes.
    Reardon W; Genet S; Middleton-Price H; Malcolm S; Feighery C
    Ir Med J; 1991 Dec-1992 Jan; 84(4):116-8. PubMed ID: 1817116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agammaglobulinemia and insights into B-cell differentiation.
    Manis J; Schwartz RS
    N Engl J Med; 1996 Nov; 335(20):1523-5. PubMed ID: 8890105
    [No Abstract]   [Full Text] [Related]  

  • 15. The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans.
    Aruffo A; Hollenbaugh D; Wu LH; Ochs HD
    Curr Opin Hematol; 1994 Jan; 1(1):12-8. PubMed ID: 9371254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and genetic approaches to the isolation of the gene for X-linked agammaglobulinemia.
    Kinnon C; Lovering R; O'Reilly MA; Sweatman A; Bradley L; Parkar M; Alterman L; Levinsky R
    Immunodeficiency; 1995; 5(3):179-85. PubMed ID: 7749437
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.
    Smith CI; Baskin B; Humire-Greiff P; Zhou JN; Olsson PG; Maniar HS; Kjellén P; Lambris JD; Christensson B; Hammarström L
    J Immunol; 1994 Jan; 152(2):557-65. PubMed ID: 8283037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells in patients with X-linked and 'common variable' hypogammaglobulinaemia.
    Golay JT; Webster AD
    Clin Exp Immunol; 1986 Jul; 65(1):100-4. PubMed ID: 3539422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closing in on type 1 diabetes.
    McDevitt H
    N Engl J Med; 2001 Oct; 345(14):1060-1. PubMed ID: 11586961
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
    Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
    J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.